The short version of reconstitution fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-11-12 and is reviewed periodically as new material appears.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
TB-500 is a synthetic heptapeptide with the sequence Ac-LKKTETQ. It corresponds to a short N-terminal region of thymosin beta-4, a 43-amino-acid protein found in many cell types. The fragment contains an actin-binding motif, which is one reason it appears in laboratory studies of cell migration and cytoskeletal dynamics. TB-500 is not the full-length protein and is produced as a research chemical rather than an approved therapeutic agent. Its molecular weight is approximately 889 Da.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | Approximately 4963 Da for full-length thymosin beta-4 | Value applies to the parent protein; fragment products may differ |
| Appearance | White to off-white lyophilized powder | Typical form of supplied synthetic peptide |
| Solubility | Freely soluble in water | Polar peptide; dissolves readily in aqueous buffer |
| Storage of dry powder | −20 °C, desiccated, protected from light | Standard laboratory practice for peptides |
| Typical detection method | Liquid chromatography–tandem mass spectrometry | Used in purity testing and anti-doping analysis |
Material sold under this label typically arrives as a freeze-dried powder in a sealed vial with a certificate of analysis. Such certificates usually report reversed-phase chromatography purity plus a mass confirmation, and stated purities commonly sit between 95 and 99 percent. Counter-ion identity, residual trifluoroacetate, water content, and peptide net weight are separate specifications that a certificate may or may not include. A purity figure alone does not establish sequence identity, so independent mass verification remains the practical check.
The designation TB-500 circulates in laboratory and catalog contexts without a single agreed definition. Most product listings apply it to an N-terminally acetylated seven-residue fragment of thymosin beta-4, while other listings attach the same label to the full 43-residue protein. Because the term is commercial rather than systematic, two entries bearing identical names may describe different molecules. Any documentation should therefore state which sequence a given sample is claimed to contain.
Full-length thymosin beta-4 consists of roughly forty-three amino acids and ranks among the more abundant small proteins in the cytoplasm. The fragment is much shorter, so it cannot reproduce every function attributed to the intact molecule. In cell culture, short actin-binding motifs can interfere with filament dynamics and cell movement, but such observations come from controlled experiments rather than from whole-animal work. Whether a truncated fragment produces the same effects as the parent protein remains an open question.
Interest in the peptide grew during the 2000s and 2010s, when studies of tendon and ligament injuries in horses reported changes in lesion size after treatment. Those reports circulated widely outside the scientific literature and shaped much of the current online discussion. Subsequent reviews noted inconsistent study design, small groups, and a shortage of independent replication. Popular descriptions often blur the line between the fragment, the complete protein, and unrelated growth factors, which complicates comparisons across sources.
TB-500 is a synthetic peptide whose sequence corresponds to a short fragment near the N-terminus of thymosin beta-4, a small protein present in most mammalian cells. The fragment is commonly cited as containing the actin-binding region of the parent molecule, which is why it appears in laboratory work on cell migration and tissue repair. Suppliers distribute it as a lyophilised powder intended for research use. Its identity is defined by amino acid sequence and by the presence of an acetyl group on the N-terminal residue.
Reconstitution of a lyophilized peptide is normally done with sterile water or a suitable buffer under aseptic conditions. Adding solvent down the vial wall and allowing gentle dissolution instead of vigorous vortexing reduces the chance of aggregation, which can lower the effective concentration of the resulting solution. Concentrated stocks are usually diluted into working buffer shortly before use. Because no standard preparation protocol exists for TB-500 specifically, laboratories adapt general peptide handling practice, and reported results may reflect differing preparation choices.
Dry peptide powder is commonly kept at −20 °C in a desiccated container away from light, a practice that limits moisture uptake and oxidation. Once dissolved, solutions are generally held at 2–8 °C for short periods or frozen at −20 °C or lower for longer storage, with repeated freeze-thaw cycles avoided. Hydrolysis and oxidation are the main degradation routes for peptides in solution, and both accelerate at higher temperature or extreme pH. Published stability data specific to TB-500 are limited, so shelf life should be treated as uncertain.
Lyophilized TB-500 is hygroscopic and should be kept dry before use. The usual storage recommendation for the solid is -20 °C, protected from light and moisture. Once dissolved, the peptide is less stable, and repeated freeze-thaw cycles can promote aggregation or degradation. Laboratories often divide a reconstituted solution into single-use aliquots and store them at -80 °C. Exact stability limits depend on buffer, pH, and concentration, so published data do not define a single universal condition.
Identity and purity are checked with chromatographic and mass spectrometric methods. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities, while mass spectrometry confirms the expected molecular mass. A certificate of analysis may report a purity percentage, but the laboratory should still verify the material independently. Common quality concerns include truncated sequences, deamidation, oxidation, and residual solvents from synthesis. Because TB-500 is short, some impurities can differ from the target by only a few mass units.
Reconstitution practices affect downstream measurements. The dry powder is typically dissolved in sterile water or a suitable aqueous buffer, then mixed gently rather than vortexed at high speed. Visible particles or cloudiness suggest incomplete dissolution or contamination and should be investigated. For long-term storage, aliquots should be labeled with concentration, solvent, and date. Open questions include how different buffers alter peptide conformation and whether specific container materials adsorb the peptide. Those variables can change apparent concentration in assays even when the chemical identity is correct.
=== Ancient use === Various isolated examples of the use of impure zinc in ancient times have been discovered. Zinc ores were used to make the zinc–copper alloy brass thousands of years prior to the discovery of zinc as a separate element. Judean brass from the 14th to 10th centuries BC contains 23% zinc. Knowledge of how to produce brass spread to Ancient Greece by the 7th century BC, but few varieties were made. Ornaments made of alloys containing 80–90% zinc, with lead, iron, antimony, and other metals making up the remainder, have been found that are 2,500 years old. A possibly prehistoric statuette containing 87.5% zinc was found in a Dacian archaeological site. Strabo writing in the 1st century BC (but quoting a now lost work of the 4th century BC historian Theopompus) mentions "drops of false silver" which when mixed with copper make brass. This may refer to small quantities of zinc that is a by-product of smelting sulfide ores. Zinc in such remnants in smelting ovens was usually discarded as it was thought to be worthless. The manufacture of brass was known to the Romans by about 30 BC. They made brass by heating powdered calamine (zinc silicate or carbonate), charcoal and copper together in a crucible. The resulting calamine brass was then either cast or hammered into shape for use in weaponry. Some coins struck by Romans in the Christian era are made of what is probably calamine brass.
Jack Schmidt was the first person commissioned to paint the original In-N-Out located in Baldwin Park, California for In-N-Out Burger Inc. His paintings were later reproduced on advertisements, shirts, and other consumer products. The 2022 shirt design was created by Palm Springs, California artist Danny Heller.
== Structure == Drosophila contain a single Notch protein, C. elegans contain two redundant notch paralogs, Lin-12 and GLP-1, and humans have four Notch variants, Notch 1-4. Although variations exist between homologs, there are a set of highly conserved structures found in all Notch family proteins. The protein can broadly be split into the Notch extracellular domain (NECD) and Notch intracellular domain (NICD) joined together by a single-pass transmembrane domain (TM). The NECD contains 36 EGF repeats in Drosophila, 28-36 in humans, and 13 and 10 in C. elegans Lin-12 and GLP-1 respectively. These repeats are heavily modified through O-glycoslyation and the addition of specific O-linked glycans has been shown to be necessary for proper function. The EGF repeats are followed by three cysteine-rich Lin-12/Notch Repeats (LNR) and a heterodimerization (HD) domain. Together the LNR and HD compose the negative regulatory region adjacent to the cell membrane and help prevent signaling in the absence of ligand binding. NICD acts as a transcription factor that is released after ligand binding triggers its cleavage. It contains a nuclear localization sequence (NLS) that mediates its translocation to the nucleus, where it forms a transcriptional complex along with several other transcription factors. Once in the nucleus, several ankyrin repeats and the RAM domain interactions between the NICD and CSL proteins to form a transcriptional activation complex. In humans, an additional PEST domain plays a role in NICD degradation.
Hess' law of constant heat summation Also simply called Hess' law. A law of physical chemistry which states that the total enthalpy change during the course of a chemical reaction is the same whether the reaction is completed in one step or in multiple steps.
A hibernation factor is a protein used by cells to induce a dormant state by slowing or halting the cellular metabolism. This can occur during periods of stress, randomly in order to allocate "designated survivors" in a population, or when bacteria cease growth (enter stationary phase). Hibernation factors can do a variety of things, including dismantling cellular machinery and halting gene expression, but the most important hibernation factors bind to the ribosome and halt protein production, which consumes a large fraction of the energy in a cell.
Sources: en.wikipedia.org
Recent theoretical developments in noble gas chemistry, in which helium is expected to show slightly less inertness than neon and to form (HeO)(LiF)2 with a structure similar to the analogous beryllium compound (but with no expected neon analogue), have resulted in more chemists advocating a placement of helium in group 2. This relates to the electronic argument, as the reason for neon's greater inertness is repulsion from its filled p-shell that helium lacks, though realistically it is unlikely that helium-containing molecules will be stable outside extreme low-temperature conditions (around 10 K). The first-row anomaly in the periodic table has additionally been cited to support moving helium to group 2. It arises because the first orbital of any type is unusually small, since unlike its higher analogues, it does not experience interelectronic repulsion from a smaller orbital of the same type. This makes the first row of elements in each block have unusually small atoms, and such elements tend to exhibit characteristic kinds of anomalies for their group. Some chemists arguing for the repositioning of helium have pointed out that helium exhibits similar anomalies if it is placed in group 2, but not if it is placed in group 18: on the other hand, neon, which would be the first group 18 element if helium was removed from that spot, does exhibit similar anomalies. The relationship between helium and beryllium is then argued to resemble that between hydrogen and lithium, a placement which is much more commonly accepted.
=== Temperature and relative humidity === Organic materials are porous by nature, which means that they are greatly affected by changes in the moisture levels of their surroundings. Overly moist conditions can lead to growth of fungi on protein materials like human remains, which is one of the most common risks they face. Alternately, low-humidity conditions can potentially cause protein materials to crack, split, and shrink. Ideal storage conditions for bones is 35% to 55% relative humidity with minimal fluctuations, while ideal conditions for the preservation of mummies are 50 to 59 degrees Fahrenheit (10 to 15 degrees Celsius) with a relative humidity of 40% to 55%.
Gavin Christopher Newsom (born October 10, 1967) is an American politician and businessman serving since 2019 as the 40th governor of California. A member of the Democratic Party, he served from 2011 to 2019 as the 49th lieutenant governor of California and from 2004 to 2011 as the 42nd mayor of San Francisco. Born and raised in San Francisco, Newsom graduated from Santa Clara University in 1989 with a Bachelor of Science in political science. Afterward, he founded the boutique winery PlumpJack Group in Oakville, California, with billionaire heir and family friend Gordon Getty as an investor. The company grew to manage 23 businesses, including wineries, restaurants, and hotels. Newsom began his political career in 1996, when San Francisco mayor Willie Brown appointed him to the city's Parking and Traffic Commission. Brown then appointed Newsom to fill a vacancy on the Board of Supervisors the next year and Newsom was first elected to the board in 1998. Newsom was elected mayor of San Francisco in 2003 and reelected in 2007. He was elected lieutenant governor of California in 2010 and reelected in 2014. As lieutenant governor, Newsom hosted The Gavin Newsom Show from 2012 to 2013 and in 2013 wrote the book Citizenville, which focuses on using digital tools for democratic change. Newsom was elected governor in 2018 and reelected in 2022. He faced criticism for his personal behavior and leadership style during the COVID-19 pandemic, which contributed to an unsuccessful recall effort in 2021.
SNAP-tag® is a self-labeling protein tag commercially available in various expression vectors. SNAP-tag is a 182 residue polypeptide (19.4 kDa) that can be fused to any protein of interest and further specifically and covalently tagged with a suitable ligand, such as a fluorescent dye. Since its introduction, SNAP-tag has found numerous applications in biochemistry and for the investigation of the function and localisation of proteins and enzymes in living cells.
William Clark Still (born 1946) is an American organic chemist. As a distinguished professor at Columbia University, Clark Still made significant contributions to the field of organic chemistry, particularly in the areas of natural product synthesis, reaction development, conformational analysis, macrocyclic stereocontrol, and computational chemistry. Still and coworkers also developed the purification technique known as flash column chromatography, which is widely used for the purification of organic compounds.
Sources: en.wikipedia.org
== R == random primed synthesis - reading frame - recessive - recognition sequence - recombinant DNA - recombination - recombination-repair - relaxed DNA - repetitive DNA - replica plating - reporter gene - repression - repressor - residue - response element - restriction - restriction endonuclease - restriction enzyme - restriction fragment - restriction fragment length polymorphism (RFLP) - restriction fragments - restriction map - restriction site - reticulocyte lysate - retrovirus - reverse transcriptase - reverse transcription - revertant - ribonuclease - ribonuclease - ribonucleic acid - riboprobe - ribose-seq - ribosomal-protein-alanine N-acetyltransferase - ribosomal binding sequence - ribosome - ribosyldihydronicotinamide dehydrogenase (quinone) - ribozyme - risk communication - RNA polymerase - RNA splicing - RNAi - RNase - RNase protection assay - rRNA - rRNA (guanine-N2-)-methyltransferase - RT-PCR - Run-on - runoff transcript
These same women were also subject to extremely long and extensive interviews so that the Population Council's International Population Program could document their marital and fertility histories. This same secrecy and oppression was experienced by Puerto Rican women as they were unknowingly being tested for the Depo Privera shot and contraceptive foam. Once the implications of sterilizations became more widely known, many women opted to take other forms of contraception during the dangerous phases of development to avoid the permanent procedure.
== Further reading == Gessner, T.; Mayer, U. (2002). "Triarylmethane and Diarylmethane Dyes". Ullmann's Encyclopedia of Industrial Chemistry 6th Edition. Weinheim: Wiley-VCH. doi:10.1002/14356007.a27_179. ISBN 978-3527306732.
A post hoc analysis from a randomized, placebo-controlled, multi-centre study carried out at 11 secondary care centres, as well as a longitudinal single-centre study on pregnant women in Norway, also determined that metformin had no effect on maternal androgens in pregnancies occurring in the setting of PMOS. One systemic review suggested that polymorphisms in the vitamin D receptor gene are associated with the prognosis of polyendocrine metabolic ovarian syndrome, though this is based on small sample sizes and is debated. Studies have shown benefits for vitamin D supplementation in women with vitamin D deficiency and PMOS. Hyperinsulinemia can increase the production of androgens in the ovaries. One context in which this occurs is HAIR-AN syndrome, a rare subtype of PMOS.
Sources: en.wikipedia.org
Not necessarily. TB-500 is a commercial label that suppliers apply to synthetic peptides described as thymosin beta-4 or a fragment of it. Published research most often studies the full-length protein, so statements about one do not automatically transfer to the other.
No. No major regulatory authority lists an approved product under this name, and no pharmacopoeial monograph exists for it. Material sold under the label is therefore supplied outside approved pharmaceutical channels, which affects the quality documentation available.
It falls within a prohibited class covering peptide hormones and growth factors, based on presumed effects on tissue repair and blood vessel formation. Anti-doping laboratories have published mass spectrometry methods for detecting thymosin beta-4 related peptides in urine samples.
TB-500 is a synthetic heptapeptide corresponding to a fragment of thymosin beta-4. It is used in laboratory research and is not an approved drug.